Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a Canada-based specialty pharmaceutical company. The Company's principal business activity includes developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invested in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The Company's portfolio consists of pharmaceutical products with molecules and includes both in-licensed products, such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome as well as products owned (or partially owned) by it, such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by MrMugsyon Feb 25, 2022 11:42am
108 Views
Post# 34461658

RE:Large Stock positions!?

RE:Large Stock positions!?
Lookingforclues wrote:

 Checked amount of Shares held by Execs of GUD......poor number!

Out of 100M plus, they own only a Few Million between them.....shows their Committment to this poorly run Company......



That's kind of unlikely considering Goodman owns roughly 20% on his own.
So I can safely guess insiders own at least 20% of the company.
That on its own is quite good.

Then you have Samira who has always been relatively conservative and that's absolutely what I expect from a finanance person.  Her ownership will start to rise faster now that she is CEO and I'm sure she'll start to buy a little more due to her higher wages.

If you compare to Paladin - there really isn't anything different.  The characteristics are the same with respect to buying shares and ownership ... but nice try !

Remember - slow and steady - that's what you will also see from them in every aspect of GUD, including share purchases.
<< Previous
Bullboard Posts
Next >>